Početna › Rak mjehura
Kliničke studije za Rak mjehura koje traže sudionike u SAD-u
142 studija za Rak mjehura traži sudionike na lokacijama širom Sjedinjenih Američkih Država.
Gradovi s najviše studija
- New York City, NY35 studija
- Nashville, TN31 studija
- Houston, TX31 studija
- Dallas, TX27 studija
- Boston, MA26 studija
- Washington, DC26 studija
- Los Angeles, CA24 studija
- Baltimore, MD24 studija
- St. Louis, MO22 studija
- Philadelphia, PA21 studija
- Seattle, WA21 studija
- Edison, NJ21 studija
- Chicago, IL21 studija
- Durham, NC20 studija
- Columbus, OH19 studija
- Cleveland, OH18 studija
- Queens, NY16 studija
- Atlanta, GA16 studija
- Baldwin Park, CA14 studija
- San Francisco, CA13 studija
- Portland, OR13 studija
- San Antonio, TX13 studija
- Rochester, MN12 studija
- Kansas City, KS12 studija
- Austin, TX12 studija
- Orange, CA12 studija
- Grand Rapids, MI12 studija
- San Diego, CA11 studija
- Birmingham, AL11 studija
- Milwaukee, WI11 studija
- Denver, CO11 studija
- Detroit, MI11 studija
- Irvine, CA11 studija
- Staten Island, NY11 studija
- New Rochelle, NY11 studija
- Minneapolis, MN11 studija
- Oklahoma City, OK11 studija
- Myrtle Beach, SC10 studija
- Omaha, NE10 studija
- Kansas City, MO10 studija
Po državama
- Alabama11 studija
- Aljaska3 studija
- Arizona20 studija
- Arkansas15 studija
- Colorado20 studija
- Connecticut9 studija
- Delaware4 studija
- Distrikt Columbia17 studija
- Florida38 studija
- Georgia19 studija
- Idaho6 studija
- Illinois30 studija
- Indiana14 studija
- Iowa12 studija
- Kalifornija54 studija
- Kansas17 studija
- Kentucky7 studija
- Louisiana13 studija
- Maryland36 studija
- Massachusetts31 studija
- Michigan25 studija
- Minnesota24 studija
- Mississippi3 studija
- Missouri27 studija
- Montana7 studija
- Nebraska11 studija
- Nevada5 studija
- New Hampshire3 studija
- New Jersey26 studija
- New Mexico3 studija
- New York41 studija
- North Carolina26 studija
- North Dakota4 studija
- Ohio36 studija
- Oklahoma12 studija
- Oregon14 studija
- Pennsylvania27 studija
- Rhode Island4 studija
- South Carolina16 studija
- South Dakota4 studija
- Tennessee34 studija
- Texas51 studija
- Utah14 studija
- Vermont3 studija
- Virginia24 studija
- Washington25 studija
- West Virginia5 studija
- Wisconsin17 studija
- Wyoming4 studija
Nedavno ažurirane studije
Službeni tekst studije (engleski)
Evaluation for NCI Surgery Branch Clinical Research Protocols
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT00001823A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06465069KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07232602En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
U tijeku regrutacijaOpažajna studija
Od 18 do 120 godina · Oba spola · Ažurirano 2. lis 2026. · NCT04235764Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07000084Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06770582A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06760819Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial
U tijeku regrutacijaFaza 4
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06764095A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06833073A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06172478A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07090499Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06263153Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07664397Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07061964Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06470282Enfortumab Vedotin and Stereotactic Radiation for Localized Bladder Cancer
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT06394570Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07667335Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 2 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT00026884Patient-Centered Surgical Prehabilitation
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 do 85 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT05715684The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07285044Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07566156Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT03866382DK222 Study at Hopkins
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07140315Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07421700Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.